SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Meta-Iodobenzylguanidine (131I) [131I] iobenguane is GE Healthcare Limited Amersham Place Little Chalfont Buckinghamshire HP7 9NA United Kingdom 8 MARKETING AUTHORISATION NUMBER
I-131-MIBG therapy puts radiation inside the body to kill cancer cells. In the Pacific Northwest, only Seattle Children’’s offers this therapy for kids.
Search Results for ”Ge Healthcare Iobenguane MIBG I131”
PRINCETON, NJ — Almost four years after the company submitted its application to the FDA, GE Healthcare has announced approval of an expanded indication for its iobenguane I 123 injection
and Development, GE Healthcare, Princeton, New Jersey Although 123 I-MIBG has been in clinical use for the imaging of pheochromocytoma for many years, a …
123 I-MIBG Imaging: Patient Preparation and Technologist’s Role S. Seth Van Vickle, CNMT, NCT, and The radiopharmaceutical 123 I-metaiodobenzylguanidine (MIBG) (AdreView; GE Healthcare) GE Healthcare website.
Welcome to the GE Healthcare Life Sciences Certificates Search. This is your one-stop place to search and download Certificates of Analysis for our Core Imaging products.
Meta-Iodobenzylguanidine (131i) For Diagnostic Use 9.25 -18.5 Mbq/Ml Solution For Injection Out of date information, [131 l]iobenguane. Each vial of MIBG Diagnostic contains between 9.25-18.5 MBq/ml (Megabecquerel – the unit in which radioactivity is measured) of iodine-131) at a fixed time. GE Healthcare Limited Amersham Place …
Read all of this leaflet carefully before you are given MIBG Diagnostic. PackaGe LeaFLeT: InFoRMaTIon FoR The UseR Meta-Iodobenzylguanidine (131I) for …
GE Healthcare has recently submitted a New Drug Application (NDA) for Iobenguane I 123 Injection ([123I]mIBG (AdreView)) as a diagnostic nuclear imaging agent for the detection of primary or metastatic neuroblastoma and pheochromocytoma. The present protocol establishes an Expanded Access program to